Can Weight-Loss Medications Help You Breathe Better In Your Sleep?

Imagine constantly waking up exhausted even after a full night’s sleep. For millions of people across the world, this is a reality and is caused by obstructive sleep apnea (OSA). Now imagine that this could be helped by simple medications originally developed for diabetes and weight loss. Recent studies suggest that medications called glucagon-like peptide-1 (GLP-1) receptor agonists may offer a promising new approach to managing OSA (Dandamudi et al. 2026).

What Is Obstructive Sleep Apnea?

First of all, what is OSA? OSA is a medical condition where the upper airway repeatedly becomes partially or completely blocked during sleep (Slowik et al. 2025). When the muscles that surround the airway relax during sleep, the throat can narrow or collapse, temporarily interrupting breathing. These interruptions lower oxygen levels and disrupt sleep, often causing loud snoring and excessive daytime tiredness. It can also affect cardiovascular health, mental well-being, quality of life, and driving safety (Slowik et al. 2025).

One of the majour risk factors for OSA is obesity. Obesity can cause things like excess fat at the neck, which can increase the pressure on the upper airway. Additionally, accumulation of abdominal fat caused by obesity can limit diaphragmatic movement, compromise airway stability, and even reduce lung volume. It is estimated that for every 10% increase in body mass index, OSA risk increases by approximately six-fold. This is why using a drug originally developed for weight loss can potentially help reduce the effect of OSA (Fang et al. 2026).

What Are GLP-1 Medications?

GLP-1 is a naturally occurring hormone in the small intestine that is responsible for many key functions, including helping to regulate blood sugar and appetite. It does this by stimulating insulin release, slowing stomach emptying, and increasing feelings of fullness. GLP-1 agonist medications work in a similar way, as they mimic this hormone, helping individuals manage blood sugar and lose weight (Clevel. Clin. 2023). A prominent example of this is the medication tirzepatide, which activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, allowing it to target multiple pathways involved in metabolism and weight regulation (Fang et al. 2026).

How Can GLP-1 Medications Improve Sleep Apnea?

So, how exactly can medications that were originally made for diabetes and weight management improve OSA? Tirzepatide, specifically, may work through three main mechanisms: metabolic regulation, reduced inflammation, and improved upper airway muscle function (Fang et al. 2026).

The first mechanism is metabolic regulation. Since tirzepatide activates both GLP-1 and GIP receptors, it can increase the feelings of fullness and reduce appetite, promoting weight loss. This may reduce fat accumulation around the neck and abdomen, decreasing pressure on the upper airway and making it less likely to collapse during sleep (Fang et al. 2026).

The second mechanism involves reducing inflammation. When the GLP-1 receptor is activated, it can influence AMP-activated protein kinase, which can subsequently suppress the NF-κB signalling pathway. This then reduces pro-inflammatory cytokine production, potentially improving respiratory function (Fang et al. 2026).

Finally, tirzepatide can contribute to neuromuscular improvements. Animal studies have suggested that GLP-1 signalling can increase the tone of the genioglossus, which is a tongue muscle that helps keep the upper airway open. This could then reduce airway collapse during sleep; however, it is important to note that this effect has not been established in humans (Fang et al. 2026).

Importantly, clinical research has supported these potential benefits. A pooled analysis found that GLP-1-based treatment reduced the apnea-hypopnea index, which measures the number of breathing interruptions per hour, by approximately 13.89 interruptions per hour. Additionally, participants experienced an average weight reduction of 12.46 kg. This supports the suggested connection between weight loss and improved OSA (Dandamudi et al. 2026).

A New Approach to Sleep Apnea Treatment!

Although more research is needed to fully understand the mechanisms involved in GLP-1 medications, they still offer a promising approach in managing OSA. By targeting weight, inflammation, and airway muscle function, these medications may not only improve metabolic health. They could also help people achieve a better night’s sleep, which is something I’m sure we can all appreciate.

References

Cleveland Clinic. 2023. “GLP-1 Agonists.” March 7. https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists.

Dandamudi, Mrunalini, Larissa Lucena, Nicole Norma Gamarra-Valverde, et al. 2026. “Efficacy of GLP-1 Receptor Agonists in Treating Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis of Cardiometabolic and Respiratory Outcomes.” Sleep & Breathing = Schlaf & Atmung 30 (2): 138. https://doi.org/10.1007/s11325-026-03681-4.

Fang, Qiujie, Yipeng Zhu, Mei Rao, and Peijun Liu. 2026. “GLP-1/GIP Dual Agonist Tirzepatide in Obstructive Sleep Apnea Syndrome: Mechanisms, Evidence, and Clinical Perspectives.” Frontiers in Medicine 13 (April). https://doi.org/10.3389/fmed.2026.1752341.

Slowik, Jennifer M., Abdulghani Sankari, and Jacob F. Collen. 2025. “Obstructive Sleep Apnea.” In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK459252/.

Comments

5 Responses to “Can Weight-Loss Medications Help You Breathe Better In Your Sleep?”

  1. Claire Chisholm Avatar
    Claire Chisholm

    Hey Isci,

    I decided to write about how GLP-1 medications can improve sleep apnea because it came up in one of my classes, and I thought the idea was really cool. It also reminded me of Charles Boyle from Brooklyn 99, so that was a little more inspiration for me to write about this.

    Hope you enjoy!
    – Claire

  2. Berk Coskun Avatar
    Berk Coskun

    Hi Claire!

    This was an awesome blog post. I really liked the topic and I never really explored GLP-1 medication for sleep applications so that was really interesting to see.

    Some small advice:

    – Consider adding a figure to better enhance your writing. I think one for the data analysis results for Dandamudi et al. 2026 may make sense?
    – This post explores a lot of the advantages of GLP-1 medication but also omits large potential side effects and limitations. I think that adding that comparison would help with a more balanced/unbiased view.
    – Under the subtitle of “What Is Obstructive Sleep Apnea,” you repeat the question in your first sentence with “First of all, what is OSA?” This was already asked by your subtitle so you don’t need to restate it.
    – Change “…these medications may not only improve metabolic health. They could also help…” to “…these medications may not only improve metabolic health, but also help…” to help flow in my opinion.

    Happy editing,
    Berk 🙂

  3. Aaliya Avatar
    Aaliya

    Hi Claire! I loved your blog post topic! I’ve never actually heard of weight loss medication being used in that way! That being said, I do have a bit of feedback to improve the overall flow of your post! First, I think your point would benefit from a figure, maybe showing the structure of the airway or even just a chart showing the effects of GLP-1 on Sleep apnea; that would really support the argument and help readers get a sense of what is actually being discussed. Secondly I believe the argument can also benefit from an actually quantitate substantiation i.e a statistic of people that felt that their sleep improved. Lastly, I think you could expand a bit more on OPS, including more detail on the demographics of people who struggle with it. Overall, you did a great job on your piece, and I’m excited to read the final draft!

  4. Aaron Ling Avatar
    Aaron Ling

    Hey Claire!

    This was honestly really interesting to read, and the fact that you got this topic from Boyle was pretty funny. The only thing I’d recommend would be to add a figure or two, such as a diagram of the airways or how the activation of the GLP-1 and GIP receptors work.

    Otherwise really good work!

    Aaron

  5. Kurtis Ng Avatar
    Kurtis Ng

    Hi Claire!

    This was a really interesting read! Here are some suggestions for improvements:

    – P3S4: “It is estimated that for every 10% increase in body mass index, OSA risk increases by approximately six-fold.” I think this big number needs its own citation right after it. It looks like it comes from Peppard et al. (2000, JAMA), which found that a 10% increase in body weight (not BMI) was linked to about 6 times the odds of developing moderate-to-severe sleep apnea, so you could try rewording it to match.

    – P4S3: “…helping individuals manage blood sugar and lose weight (Clevel. Clin. 2023).” Small thing, but the in-text citation is abbreviated, so maybe change it to (Cleveland Clinic 2023) to match your reference list.

    – P7S2: “When the GLP-1 receptor is activated, it can influence AMP-activated protein kinase, which can subsequently suppress the NF-κB signalling pathway.” I think this is the hardest sentence for a general reader. You could try a quick plain-language explanation (for example, that these are signalling steps that turn down inflammation) and a line on why less inflammation matters for the airway.

    – P9S2: “…reduced the apnea-hypopnea index… by approximately 13.89 interruptions per hour.” I think this number is the average difference compared with placebo across four randomized trials, so you could try adding “compared with placebo” so readers don’t assume it’s a before-and-after change.

    I didn’t realize a tongue muscle called the genioglossus helps keep the airway open during sleep! Can’t wait to see the final copy!

    – Kurtis

Leave a Reply